| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702689 | Urologic Oncology: Seminars and Original Investigations | 2017 | 8 Pages |
Abstract
VEGF has prognostic value in clear cell renal cell carcinoma, and ERK5 may be a new prognostic marker in this type of tumor owing to its relationship with metastasis and more advanced stages.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Leticia Ph.D., José M. Ph.D., M.D., Syongh Y. M.D., Francisco J. Ph.D., Jesús Ph.D., Ricardo Ph.D., Antonio S. Ph.D., M.D.,